Exocrine pancreatic function in cystic fibrosis

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 8, 1996, Pages 755-759

  Guy Crotte, Odette ^a   Carrère, Jacqueline ^a   Figarella, Catherine ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cystic fibrosis; Dysfunction; Exocrine pancreas; Genotype

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN;

BLOOD LEVEL; CYSTIC FIBROSIS; GENE MUTATION; HUMAN; PANCREAS DISEASE; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PRENATAL DISORDER; PRIORITY JOURNAL; REVIEW;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXOCRINE PANCREATIC INSUFFICIENCY; FETUS; GENE EXPRESSION; HUMANS; PANCREAS; PANCREATITIS;

EID: 0029792590     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Andersen DH: Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child 1938, 56:344-399.
2. Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, et al: Identification of the cystic fibrosis gene: chromosomes walking and jumping. Science 1989, 245:1059-1065.
3. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, et al.: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1072.
4. Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al.: Identification of the cystic fibrosis gene: genetic analysis. Science 1989, 245:1073-1080.
5. Boué A, Muller F, Nezeloff C, Oury JF, Duchatel F, Dumez Y, et al.: Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum Genet 1986, 74:288-297.
6. Carrère J, Muller F, Boué A, Guy-Crotte O, Figarella C: Levels and molecular forms of immunoreactive trypsin and chymotrypsin in amniotic fluids from normal and cystic fibrosis fetus: evidence for a lack of activation of proteolytic zymogens in cystic fibrosis fetus. J Pediatr Gastroenterol Nutr 1992, 14:198-203.
7. Heeley AF, Bangert SK: The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood. Ann Clin Biochem 1992, 29:361-376.
8. Figarella C: Quelle approche pour le dépistage néonatal de la mucoviscidose? Immunoanal Biol Spec 1992, 33:77-81. Assays of serum immunoreactive trypsin must be optimized and remain the best neonatal screening of cystic fibrosis.
9. Crossley JR, Elliot RP, Smith PA: Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1979, i:472-474
10. Carrère J, Estevenon JP, Guy-Crotte O, Thouvenot JP, Figarella C: Physiologically elevated concentration of serum trypsin-like immunoreactivity in newborns. Comparison with lipase. Biol Neonate 1986, 49:113-120.
11. Imrie JR, Fagan DG, Sturgess JM: Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol 1979, 95:697-708.
12. 1-proteinase inhibitor in meconium from healthy infants and infants with cystic fibrosis. In Marker Proteins in Inflammation. Edited by Arnaud P, Bienvenu J, Laurent P. Berlin: Walter de Gruyter; 1984:251-254.
13. Hsieh M, Berry HK: Proteinase inhibitor and defective proteolysis in cystic fibrosis. Dig Dis Sci 1988, 33:282-288.
14. Figarella C: The evolution of pancreatic disease in cystic fibrosis. In Cystic Fibrosis - Current Topics, vol 2. Edited by Dodge JA, Brock DJH, Widdicombe JH. Chichester: John Wiley; 1994:255-275.
15. DiMagno EP, Co VLW, Summerskill WH: Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973, 288:813-815.
16. Gaskin KJ, Durie PR, Lee L, Hill R, Forstner G: Colipase and lipase secretion in childhood onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology 1984, 86:1-7.
17. Waters DL, Dorney S, Gaskin KJ, Gruca MA, O'Halloran M, Wicken B: Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990, 332:303-308.
18. Gaskin K, Waters D, Dorney S, Gruca M, O'Halloran M, Wicken B: Assessment of pancreatic function in screened infants with cystic fibrosis. Pediatr Pulmonol 1991, (suppl. 7):69-71.
19. . Masoero C, Andriulli A, Santini B, Benitti V, Ansaldi N, Verme G: Serum trypsinlike immunoreactivity in cystic fibrosis. Am J Dis Child 1983, 137:167-170.
20. Durie PR, Forstner GG, Gaskin KJ, Moore DJ, Cleghorn GJ, Wong SS, et al.: Age-related alterations of immunoreaclive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic sufficiency. Pediatr Res 1986, 20:209-213.
21. Couper RTL, Corey M, Durie PR, Forstner GG, Moore DJ: Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic sufficient patients with cystic fibrosis. J Pediatr 1995, 127:408-413. 329 patients with CF aged 3 days to 40 years had serum levels of trypsinogen measured on 2 to 12 occasions for period ranging from 1 week to 7 years. The results show that serial measurement of serum trypsinogen is a valuable tool for monitoring the pancreatic status of patients with cystic fibrosis.
22. Couper RTL, Corey M, Moore DJ, Fisher LJ, Forstner, GG, Durie PR: Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res 1992, 32:179-182.
23. Tizzano EF, Chitayat D, Buchwald M: Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet 1993, 2:219-224. The expression of CFTR in human fetal tissues was studied at different gestational ages, 10 to 33 weeks gestation, using in-situ hybridization. The detection of CFTR transcript is consistent with the clinical manifestation of CF and the function of CFTR as a chloride channel early in development.
24. Trezise AEO, Chambers IA, Wardle CJ, Gould S, Harris A: Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet 1993, 2:213-218. The expression of CFTR has been examined in mid-trimester human fetal tissues by in-situ hybridization. CFTR mRNA was detected in the epithelia of pancreatic ducts, small intestine, colon, genital ducts, lung and trachea.
25. Kerem BS, Buchanan JA, Durie P, Corey ML, Levison H, Rommens JM, et al.: DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet 1989, 44:827-834.
26. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, et al.: The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (ΔF 508). N Engl J Med 1990, 323:1517-1522.
27. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, et al.: Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992, 50:1178-1184. The genomic DNA of 538 CF patients with well documented pancreatic function were analysed for a series of known mutations in their CFTR gene. The data showed that each genotype was associated only with PI or only with PS but not with both. This result is consistent with the hypothesis that PI and PS in CF are predisposed by the genotype at the CFTR locus.
28. - current and suggest that the residual function is sufficient to confer a milder clinical phenotype.
29. Brancolini V, Cremonesi L, Belloni E, Pappalardo E, Bardoni R, Seia M, et al.: Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations. Hum Genet 1995, 96:312-318. 31 CF patients with pancreatic sufficiency and an unidentified mutation on at least one chromosome were screened for mutations. Three new and 19 previously described mutations were detected. Among them, 17 presumed mild mutations can be considered responsible for pancreatic sufficiency.
30. 1,-proteinase inhibitor complex in some cystic fibrosis patients. Biochim Biophys Acta 1989, 993:137-142. This study shows that active trypsin has been released in blood in some sera of CF patients, suggesting that subclinical attacks of acute pancre-atitis may occur in CF patients.
31. Shwachman H, Lebenthal E, Khaw K: Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 1975, 55:86-94.
32. Kopelman HR: Cystic fibrosis. In Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis and Management. Edited by Wyllie R, Hyams JS. Philadelphia: WB Saunders; 1993:845-865.
33. Fernando del Rosario J, Putnam PE, Orenstein DM: Chronic pancreatitis in a patient with cystic fibrosis and clinical pancreatic insufficiency. J Pediatr 1995, 126:951-952.
34. Tizzano EF, Buchwald M: CFTR expression and organ damage in cystic fibrosis. Ann Intern Med 1995, 123:305-308.
35. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, et al.: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet 1996 12:280-287.